Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy

por Mc Laughlin, Anna M, Yee, Cassian
Publicado 2023

Model‐informed drug development of autologous CAR‐T cell therapy: Strategies to optimize CAR‐T cell exposure leveraging cell kinetic/dynamic modeling

por Mc Laughlin, Anna M., Milligan, Peter A., Yee, Cassian, Bergstrand, Martin
Publicado 2023

Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review

por van Dyk, Madelé, Bulamu, Norma, Boylan, Chelsea, Mc Laughlin, Anna M, Kichenadasse, Ganessan, May, Nikki, Michelet, Robin, Kloft, Charlotte, Kaambwa, Billingsley
Publicado 2021

Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review

por van Dyk, Madelé, Boylan, Chelsea, Michelet, Robin, Mc Laughlin, Anna M, Kichenadasse, Ganessan, May, Nikki, Ziesenitz, Victoria, Van Den Anker, Johannes N, Groenland, Stefanie L, Huitema, Alwin D R, Steeghs, Neeltje, Mikus, Gerd, Kloft, Charlotte, Tapp, Heather
Publicado 2022

Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol

por Mc Laughlin, Anna M., Schmulenson, Eduard, Teplytska, Olga, Zimmermann, Sebastian, Opitz, Patrick, Groenland, Stefanie L., Huitema, Alwin D. R., Steeghs, Neeltje, Müller, Lothar, Fuxius, Stefan, Illerhaus, Gerald, Joerger, Markus, Mayer, Frank, Fuhr, Uwe, Holdenrieder, Stefan, Hempel, Georg, Scherf-Clavel, Oliver, Jaehde, Ulrich, Kloft, Charlotte
Publicado 2021